Ignite Creation Date:
2025-12-24 @ 11:19 PM
Ignite Modification Date:
2026-02-23 @ 6:27 AM
Study NCT ID:
NCT03161756
Status:
UNKNOWN
Last Update Posted:
2022-04-07
First Post:
2017-05-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma
Sponsor:
Melanoma and Skin Cancer Trials Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-07
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-11
First Submit QC Date:
None
Study First Post Date:
2017-05-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-06
Last Update Post Date:
2022-04-07
Last Update Post Date Type:
ACTUAL